S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
Log in

BATS:REGLProShares S&P MidCap 400 Dividend Aristocrats ETF Stock Price, Forecast & News

$56.47
-0.12 (-0.21 %)
(As of 08/14/2020 04:00 PM ET)
Add
Today's Range
$56.13
Now: $56.47
$56.80
50-Day Range
$50.52
MA: $53.52
$56.94
52-Week Range
$50.00
Now: $56.47
$56.00
Volume68,548 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Geographic Exposure of REGL

Currency Exposure of REGL

Sector Exposure of REGL

Industry Exposure of REGL


Basic Details

Issuer ProShares
Fund NameProShares S&P MidCap 400 Dividend Aristocrats ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:REGL
Inception Date2/3/2015
Fund ManagerMichael Neches, Devin Sullivan
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkS&P MidCap 400 Dividend Aristocrats Index
CategorySize and Style
FocusMid Cap
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$731.89 million
Average Daily Volume$47,863.20
Discount/Premium0.02%

ETF Expenses

Management Fee0.40%
Other Expenses0.00%
Total Expenses0.40%
Fee Waiver0.00%
Net Expenses0.40%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerRBC Capital Markets
$56.47
-0.12 (-0.21 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive REGL News and Ratings via Email

Sign-up to receive the latest news and ratings for REGL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ProShares S&P MidCap 400 Dividend Aristocrats ETF (BATS:REGL) Frequently Asked Questions

How has ProShares S&P MidCap 400 Dividend Aristocrats ETF's stock price been impacted by COVID-19 (Coronavirus)?

ProShares S&P MidCap 400 Dividend Aristocrats ETF's stock was trading at $48.18 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, REGL stock has increased by 17.2% and is now trading at $56.4725.
View which stocks have been most impacted by COVID-19
.

How often does ProShares S&P MidCap 400 Dividend Aristocrats ETF pay dividends? What is the dividend yield for ProShares S&P MidCap 400 Dividend Aristocrats ETF?

ProShares S&P MidCap 400 Dividend Aristocrats ETF declared a quarterly dividend on Wednesday, March 25th. Stockholders of record on Thursday, March 26th will be given a dividend of $0.3935 per share on Wednesday, April 1st. This represents a $1.57 annualized dividend and a yield of 2.79%. The ex-dividend date of this dividend is Wednesday, March 25th. This is an increase from ProShares S&P MidCap 400 Dividend Aristocrats ETF's previous quarterly dividend of $0.35.
View ProShares S&P MidCap 400 Dividend Aristocrats ETF's dividend history
.

Has ProShares S&P MidCap 400 Dividend Aristocrats ETF been receiving favorable news coverage?

News articles about REGL stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. ProShares S&P MidCap 400 Dividend Aristocrats ETF earned a news sentiment score of -1.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days.
View the latest news about ProShares S&P MidCap 400 Dividend Aristocrats ETF
.

What other stocks do shareholders of ProShares S&P MidCap 400 Dividend Aristocrats ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares S&P MidCap 400 Dividend Aristocrats ETF investors own include Naspers (NPSNY), ANSELL LTD/S (ANSLY), Alimentation Couche-Tard (ANCUF), Amarin (AMRN), Amgen (AMGN), AMC Entertainment (AMC), Automatic Data Processing (ADP), Adobe (ADBE), Aurora Cannabis (ACB) and Abbott Laboratories (ABT).

What is ProShares S&P MidCap 400 Dividend Aristocrats ETF's stock symbol?

ProShares S&P MidCap 400 Dividend Aristocrats ETF trades on the BATS under the ticker symbol "REGL."

Who are ProShares S&P MidCap 400 Dividend Aristocrats ETF's major shareholders?

ProShares S&P MidCap 400 Dividend Aristocrats ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include Investment Management of Virginia LLC (0.00%), CX Institutional (0.00%), Baird Financial Group Inc. (0.00%), S. R. Schill & Associates (0.00%), Janney Montgomery Scott LLC (0.00%) and Atlas Brown Inc. (0.00%).

Which major investors are selling ProShares S&P MidCap 400 Dividend Aristocrats ETF stock?

REGL stock was sold by a variety of institutional investors in the last quarter, including Baird Financial Group Inc., Steward Partners Investment Advisory LLC, and Janney Montgomery Scott LLC.

Which major investors are buying ProShares S&P MidCap 400 Dividend Aristocrats ETF stock?

REGL stock was bought by a variety of institutional investors in the last quarter, including Investment Management of Virginia LLC, S. R. Schill & Associates, CX Institutional, Ford Financial Group LLC, Headinvest LLC, Baystate Wealth Management LLC, Essex Financial Services Inc., and Biondo Investment Advisors LLC.

How do I buy shares of ProShares S&P MidCap 400 Dividend Aristocrats ETF?

Shares of REGL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ProShares S&P MidCap 400 Dividend Aristocrats ETF's stock price today?

One share of REGL stock can currently be purchased for approximately $56.47.

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.